Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Symptom Burden of Busulfan and Melphalan Versus Melphalan Alone for Multiple Myeloma

Loretta A. Williams, PhD MSN, BSN, BA, Muzaffar H. Qazilbash, MD, Qiuling Shi, MD PhD, Qaiser Bashir, MD MBBS, Huei K. Lin, MS, Charles S. Cleeland, PhD, Richard E. Champlin, MD

Blood (2017) 130 (Supplement 1): 681.

https://doi.org/10.1182/blood.V130.Suppl_1.681.681

Published: 2017

Journal Articles

Patient-Reported Outcomes and Patient-Performed Testing in Measuring Functional Impairment after Stem Cell Transplant in Patients with Multiple Myeloma

Nina Shah, MD, Sergio A. Giralt, MD, Qiuling Shi, PhD, Loretta A. Williams, PhD APRN, Qaiser Bashir, MD, Muzaffar Qazilbash, MD, Richard E. Champlin, MD, Charles S. Cleeland, PhD, Xin Shelley Wang, MD MPH

Blood (2016) 128 (22): 538.

https://doi.org/10.1182/blood.V128.22.538.538

Published: 2016

Journal Articles

Symptom Severity Cut Points for the MD Anderson Symptom Inventory for CML (MDASI-CML)

Loretta A. Williams, PhD APRN, Qiuling Shi, PhD, Huei-Kai Lin, MS, Patricia Ault, DNP, FNP-C, Araceli Garcia-Gonzalez, MD PhD, Charles S. Cleeland, PhD, Jorge E. Cortes, MD

Blood (2016) 128 (22): 4765.

https://doi.org/10.1182/blood.V128.22.4765.4765

Published: 2016

Journal Articles

Dasatinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP) with Persistent, Low-Grade Nonhematologic Toxicity to Imatinib: Results from Dasperse (CA180-400)

Dong-Wook Kim, Charles S. Cleeland, PhD, Susanne Saussele, Loretta A. Williams, PhD APRN, Hesham Mohamed, Javier Pinilla-Ibarz, Elisabetta Abruzzese, MD

Blood (2015) 126 (23): 1575.

https://doi.org/10.1182/blood.V126.23.1575.1575

Published: 2015

Journal Articles

A Patient-Reported Outcome Measure for Symptoms and Symptom Burden of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Loretta A. Williams, PhD APRN, Araceli Garcia-Gonzalez, MD PhD, Hycienth O. Ahaneku, MBBS, DrPH, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Tito R. Mendoza, PhD, Qiuling Shi, PhD, Gautam Borthakur, MD, Jan A. Burger, MD, Elias J. Jabbour, MD, Koichi Takahashi, MD, Huei K. Lin, MS, Achala Limaye, BS, Charles S. Cleeland, PhD

Blood (2015) 126 (23): 2094.

https://doi.org/10.1182/blood.V126.23.2094.2094

Published: 2015

Journal Articles

The Significant Contribution of Pain in Determining the Health Status of Patients with Multiple Myeloma (MM)

Tito R. Mendoza, PhD, Amylou C. Dueck, PhD, Qiuling Shi, PhD, Haijun Ma, PhD, Jeffrey Zhang, PhD, Yi Qian, PhD, Charles S. Cleeland, PhD

Blood (2015) 126 (23): 4495.

https://doi.org/10.1182/blood.V126.23.4495.4495

Published: 2015

Journal Articles

Retrospective Analysis to Correlate Impact of Symptom Burden and Quality of Life to Treatment Outcome with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Chronic Phase

Binsah George, MD, Williams Lori, Quiling Shi, MD PhD, Talha Badar, MBBS,FCPS, Susan O'Brien, MD, Elias Jabbour, MD, Guillermo Garcia-Manero, MD, Nitin Jain, MD, Farhad Ravandi, MBBS, Gautam Borthakur, MD, William Wierda, MD PhD, Charles S. Cleeland, PhD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD

Blood (2014) 124 (21): 4548.

https://doi.org/10.1182/blood.V124.21.4548.4548

Published: 2014

Journal Articles

Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Loretta A. Williams, PhD RN, Hycienth Ahaneku, MBBS, MPH, Jorge E. Cortes, Guillermo Garcia Manero, MD, Hagop M. Kantarjian, MD, Qiuling Shi, PhD, Huei-Kai Lin, Achala R. Limaye, BS, Charles S. Cleeland, PhD

Blood (2014) 124 (21): 2652.

https://doi.org/10.1182/blood.V124.21.2652.2652

Published: 2014

Journal Articles

Symptom Burden of Busulfan + Melphalan Versus Melphalan Alone for Multiple Myeloma

Loretta A. Williams, PhD RN, Muzaffar H. Qazilbash, Qiuling Shi, PhD, Nina Shah, Qaiser Bashir, Richard E. Champlin, Uday R. Popat, MD, Partow Kebriaei, Simrit Parmar, Achala R. Limaye, BS, Charles S. Cleeland, PhD

Blood (2014) 124 (21): 1277.

https://doi.org/10.1182/blood.V124.21.1277.1277

Published: 2014

Journal Articles

Cytokine Profile Changes In 309 Myelofibrosis Patients: Comparison Of JAK1/JAK2 Inhibitor Therapy Vs. Placebo – Correlative Analysis From The Comfort-I Trial

Amylou C. Dueck, PhD, Charles S. Cleeland, PhD, Robert Dantzer, DVM, Jeff Sloan, PhD, Srdan Verstovsek, MD, PhD, Robyn M. Emanuel, MD, MPH, Holly Lynn Geyer, MD, Ruben A. Mesa, MD

Blood (2013) 122 (21): 4074.

https://doi.org/10.1182/blood.V122.21.4074.4074

Published: 2013

Journal Articles

Higher Stem Cell Dose Infusion As Rescue After Intensive Chemotherapy Does Not Improve Symptom Burden In Older Patients With Multiple Myeloma and Amyloidosis

Nina Shah, MD, Loretta A Williams, PhD, RN, Audrey Worthing, RN, Qiuling Shi, PhD, Xin Shelley Wang, MD, MPH, Valen Johnson, PhD, Tito R Mendoza, PhD, Muzaffar H. Qazilbash, MD, Richard E Champlin, MD, Sergio A Giralt, MD, Charles S. Cleeland, PhD

Blood (2013) 122 (21): 2161.

https://doi.org/10.1182/blood.V122.21.2161.2161

Published: 2013

Journal Articles

Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Loretta A. Williams, PhD, RN, Patricia S. Ault, MS, ACNP, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Alfonso Quintas-Cardama, MD, Gautam Borthakur, MD, Stefan H. Faderl, MD, Elias J. Jabbour, MD, Charles S. Cleeland, PhD, Jorge E. Cortes, MD

Blood (2013) 122 (21): 2988.

https://doi.org/10.1182/blood.V122.21.2988.2988

Published: 2013

Journal Articles

Relationship of Patient-Reported Symptoms to Daily Functioning in Chronic Myeloid Leukemia

Loretta A Williams, PhD, RN, Patricia S Ault, MS, ACNP, Araceli Garcia-Gonzalez, MD, Furong Huang, MS, Mary L Sailors, PhD, Charles S Cleeland, PhD, Jorge E. Cortes, MD

Blood (2012) 120 (21): 4260.

https://doi.org/10.1182/blood.V120.21.4260.4260

Published: 2012

Journal Articles

Cognitive Impairment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Desiree Jones, PhD, Elisabeth G Vichaya, PhD, Jeffrey S Wefel, PhD, Melissa S.Y. Thong, PhD, Tito R Mendoza, PhD, Loretta A Williams, PhD, RN, Charles S Cleeland, PhD, Xin Shelley Wang, MD, MPH

Blood (2012) 120 (21): 603.

https://doi.org/10.1182/blood.V120.21.603.603

Published: 2012

Journal Articles

Development of Patient-Reported Bortezomib-Induced Peripheral Neuropathyin Multiple Myeloma Patients Undergoing Induction Therapy

Xin Shelley Wang, MD, MPH, Qiuling Shi, PhD, Charles S Cleeland, PhD, Tito R Mendoza, PhD, Lori Williams, PhD, Jacqueline Joy, MS, CCRP, Venus M Ilagan, BS, Gary M Mobley, MA, Katherine R Gilmore, MPH, CCRP, Robert Z Orlowski, MD, PhD

Blood (2011) 118 (21): 677.

https://doi.org/10.1182/blood.V118.21.677.677

Published: 2011

Journal Articles

Identifying High Symptom Burden in Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitor Therapy

Loretta A Williams, PhD, RN, Patricia S Ault, MS, ACNP, Araceli Garcia-Gonzalez, MD, PhD, Quiling Shi, MD, PhD, Janet L Williams, MPH, Charles S Cleeland, PhD, Jorge E. Cortes

Blood (2011) 118 (21): 3138.

https://doi.org/10.1182/blood.V118.21.3138.3138

Published: 2011

Journal Articles

Significant Changes in Inducible Cytokine Synthesis by Activated Peripheral Blood Leukocytes of Multiple Myeloma Patients Receiving Standard Dose Autologous Stem Cell Transplantation

Bang-Ning Lee, PhD, PA-C, Nina Shah, MD, Sergio Giralt, MD, Hui Gao, PhD, Evan N Cohen, BS, Lori Williams, PhD, Ibrahima Gning, Tito R Mendoza, PhD, Jane O Brown, RN, Valen E Johnson, PhD, Richard Champlin, MD, Charles S Cleeland, PhD, James M Reuben, PhD

Blood (2011) 118 (21): 5096.

https://doi.org/10.1182/blood.V118.21.5096.5096

Published: 2011

Journal Articles

Fatigue in Chronic Myelogenous Leukemia Patients (pts) Treated with Tyrosine Kinase Inhibitors (TKI),

Aziz Nazha, Loretta A Williams, PhD, RN, Hagop M. Kantarjian, Patricia S Ault, MS, ACNP, Araceli Garcia-Gonzalez, MD, PhD, Janet L Williams, MPH, Alexandra Probst, Susan O'Brien, Elias Jabbour, Alfonso Quintas-Cardama, MD, Quiling Shi, MD, PhD, Charles S Cleeland, PhD, Jorge E. Cortes

Blood (2011) 118 (21): 3785.

https://doi.org/10.1182/blood.V118.21.3785.3785

Published: 2011

Journal Articles

The Longitudinal Relationship Between Inflammatory Markers and Patient-Reported Symptom Severity During Induction Therapy for Multiple Myeloma

Xin Shelley Wang, MD, MPH, Ping Liu, MS, Charles S Cleeland, PhD, James M Reuben, PhD, Evan N Cohen, BS, Lori Williams, PhD, Gary M Mobley, MA, Jacqueline Joy, MS, CCRP, Venus M Ilagan, BS, Katherine R Gilmore, MPH, CCRP, Tito R Mendoza, PhD, Valen E Johnson, PhD

Blood (2011) 118 (21): 4920.

https://doi.org/10.1182/blood.V118.21.4920.4920

Published: 2011

Journal Articles

Symptom Burden In Patients with Chronic Myeloid Leukemia (CML) on Kinase Inhibitor (KI) Therapy.

Loretta A Williams, PhD, RN, Araceli Garcia-Gonzalez, MD, Patricia S Ault, MS, ACNP, Janet L Williams, MPH, Gary M Mobley, MA, Tito R Mendoza, PhD, Charles S Cleeland, PhD, Jorge E. Cortes

Blood (2010) 116 (21): 3838.

https://doi.org/10.1182/blood.V116.21.3838.3838

Published: 2010

NARROW

Symptom Burden of Busulfan and Melphalan Versus Melphalan Alone for Multiple Myeloma

Patient-Reported Outcomes and Patient-Performed Testing in Measuring Functional Impairment after Stem Cell Transplant in Patients with Multiple Myeloma

Symptom Severity Cut Points for the MD Anderson Symptom Inventory for CML (MDASI-CML)

Dasatinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP) with Persistent, Low-Grade Nonhematologic Toxicity to Imatinib: Results from Dasperse (CA180-400)

A Patient-Reported Outcome Measure for Symptoms and Symptom Burden of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

The Significant Contribution of Pain in Determining the Health Status of Patients with Multiple Myeloma (MM)

Retrospective Analysis to Correlate Impact of Symptom Burden and Quality of Life to Treatment Outcome with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Chronic Phase

Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Symptom Burden of Busulfan + Melphalan Versus Melphalan Alone for Multiple Myeloma

Cytokine Profile Changes In 309 Myelofibrosis Patients: Comparison Of JAK1/JAK2 Inhibitor Therapy Vs. Placebo – Correlative Analysis From The Comfort-I Trial

Higher Stem Cell Dose Infusion As Rescue After Intensive Chemotherapy Does Not Improve Symptom Burden In Older Patients With Multiple Myeloma and Amyloidosis

Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Relationship of Patient-Reported Symptoms to Daily Functioning in Chronic Myeloid Leukemia

Cognitive Impairment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Development of Patient-Reported Bortezomib-Induced Peripheral Neuropathyin Multiple Myeloma Patients Undergoing Induction Therapy

Identifying High Symptom Burden in Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitor Therapy

Significant Changes in Inducible Cytokine Synthesis by Activated Peripheral Blood Leukocytes of Multiple Myeloma Patients Receiving Standard Dose Autologous Stem Cell Transplantation

Fatigue in Chronic Myelogenous Leukemia Patients (pts) Treated with Tyrosine Kinase Inhibitors (TKI),

The Longitudinal Relationship Between Inflammatory Markers and Patient-Reported Symptom Severity During Induction Therapy for Multiple Myeloma

Symptom Burden In Patients with Chronic Myeloid Leukemia (CML) on Kinase Inhibitor (KI) Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only